Articles by Todd L. Cecil - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Todd L. Cecil

Regulatory Compliance with One Eye on Cost

A new book attempts to reduce the confusion and costs associated with regulatory compliance.
Dec 2, 2011

A new book attempts to reduce the confusion and costs associated with regulatory compliance.

Colloids Book Helps and Confuses the Reader

Poor organization makes it hard for readers to find the helpful information in a recent book.
Jan 2, 2011

Poor organization makes it hard for readers to find the helpful information in a recent book.

Breaking Down Barriers to Oral Delivery

A recent book provides information about formulating biopharmaceuticals that is easy to swallow.
Feb 2, 2010

A recent book provides information about formulating biopharmaceuticals that is easy to swallow.

Ever Vigilant (A Pharmacovigilance Book Review)

In a recent book, UK regulators explain how to establish a pharmacovigilance system.
Apr 2, 2009

In a recent book, UK regulators explain how to establish a pharmacovigilance system.

Inside USP: Revising USP General Notices

USP is revising key documents to make them easier to use.
Aug 2, 2007

USP is revising key documents to make them easier to use.

Public Comment and Expert Oversight: The Cornerstones of USP Standards Development

USP exercises a vigorous standards-setting process that draws on both public comments and meticulous scientific review.
May 2, 2007

USP exercises a vigorous standards-setting process that draws on both public comments and meticulous scientific review.

USP's Work Plan and New Revision Approaches

Following its 2005 Convention, USP is adopting new approaches to develop monographs and products and to carry out the organization's ambitious work plans.
Oct 2, 2006

Efforts to solicit new monographs have fallen behind the rate of NDA approvals, while analytical techniques have become outdated because of advances in analytical technologies.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here